Julio Teheran and the Braves have agreed to a six-year contract extension with a team option for 2020.
Atlanta is locking up Teheran after just one full season, but it was a very impressive one as he threw 186 innings with a 3.20 ERA and 170/45 K/BB ratio as a 22-year-old. Teheran also has the track record to match, ranking among Baseball America‘s top-50 prospects in four straight seasons, including top-five rankings in 2011 and 2012.
He’s the real deal and now the Braves have him under team control through age 29, buying out all of Teheran’s arbitration-eligible seasons and as many as two of his free agency years.
UPDATE: Teheran is guaranteed $32.4 million in the deal.
MLB.com’s Brian McTaggart reports that Astros first baseman Jonathan Singleton has been suspended 100 games after testing positive for a drug of abuse for a third time. Minor league pitcher Dean Deetz has been suspended 80 games after testing positive for Dehydroclormethyltestosterone.
Singleton, 26, has had issues with marijuana in the past and opened up about his addiction several years ago. He said, “At this point it’s pretty evident to me that I’m a drug addict. I don’t openly tell everyone that, but it’s pretty apparent to myself.” He added, “I know that I enjoy smoking weed, I enjoy being high and I can’t block that out of my mind that I enjoy that. So I have to work against that.”
Singleton hasn’t played in the majors since 2015. Last season, after going all the way back to Double-A Corpus Christi, he hit .205/.376/.397 with 18 home runs and 62 RBI in 500 plate appearances.
Deetz, 24, was selected by the Astros in the 11th round of the 2014 draft. Between Corpus Christi and Triple-A Fresno last season, the right-hander posted a 4.25 ERA with a 97/50 K/BB ratio in 84 2/3 innings of work. He denies knowingly using a PED, per ESPN’s Keith Law.